These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26253518)

  • 1. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
    Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
    J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
    Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
    Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: A multicenter retrospective study of inpatients, 2009-2011.
    Magee G; Strauss ME; Thomas SM; Brown H; Baumer D; Broderick KC
    Am J Infect Control; 2015 Nov; 43(11):1148-53. PubMed ID: 26521932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
    Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
    J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
    Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
    Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
    Gabriel L; Beriot-Mathiot A
    J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of Clostridium difficile infection in a multihospital cohort of academic health centers.
    Pakyz A; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Pharmacotherapy; 2011 Jun; 31(6):546-51. PubMed ID: 21923438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
    van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
    J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
    Rodrigues R; Barber GE; Ananthakrishnan AN
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
    Mollard S; Lurienne L; Heimann SM; Bandinelli PA
    J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
    Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
    J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
    Fukuda H; Yano T; Shimono N
    Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital.
    Heimann SM; Vehreschild JJ; Cornely OA; Wisplinghoff H; Hallek M; Goldbrunner R; Böttiger BW; Goeser T; Hölscher A; Baldus S; Müller F; Jazmati N; Wingen S; Franke B; Vehreschild MJ
    Infection; 2015 Dec; 43(6):707-14. PubMed ID: 26123227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study.
    Dinh A; Le Monnier A; Emery C; Alami S; Torreton É; Duburcq A; Barbier F
    Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1297-1305. PubMed ID: 30941532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D; Prabhu VS; Marcella SW
    Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
    Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
    Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attributable costs and length of stay of hospital-acquired
    Leal JR; Conly J; Weaver R; Wick J; Henderson EA; Manns B; Ronksley P
    Infect Control Hosp Epidemiol; 2019 Oct; 40(10):1135-1143. PubMed ID: 31342884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
    Daniel A; Rapose A
    J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.